エピソード

  • Ep. 3 Designing for Cancer Care: AI, EHRs, and Real-World Clinical Insights | Dr. Stephen Speicher, Head of Clinical Oncology and Patient Safety, Flatiron Health

    Ep. 3 Designing for Cancer Care: AI, EHRs, and Real-World Clinical Insights | Dr. Stephen Speicher, Head of Clinical Oncology and Patient Safety, Flatiron Health
    2025/08/11
    The biggest breakthroughs in AI and oncology aren't just about speed, they're about bridging the gap between academic innovation and real-world care. In this episode, Dr. Stephen Speicher, Head of Clinical Oncology and Patient Safety at Flatiron Health, shares his journey from clinical practice to health tech leadership, driven by a mission to humanize care through technology. He explores how specialty-specific EHRs can address complex challenges like chemotherapy dosing and drug substitution, while highlighting the rollout of ambient AI tools to ease documentation burdens. Dr. Speicher also emphasizes the urgent need for accessible, embedded solutions in community oncology, which provides over 80% of cancer care, and discusses the real-world impact of safety, innovation, and regulatory tradeoffs. He closes with insights on building trust, bridging gaps between doctors and engineers, and turning academic advances into practical tools for frontline clinicians. Tune in and learn how AI is reducing clicks and rewriting the rules for delivering cancer care in the real world! Resources: Follow and connect with Stephen Speicher on LinkedIn. Learn more about Flatiron Health on LinkedIn and explore their website.
    続きを読む 一部表示
    47 分
  • Ep. 2 Focusing on the "Why": Technologies that Restore Purpose in Oncology | Larry Bilbrey, Director of Data Insights & Innovation, Tennessee Oncology; Senior Director of Digital Innovation, OneOncology

    Ep. 2 Focusing on the "Why": Technologies that Restore Purpose in Oncology | Larry Bilbrey, Director of Data Insights & Innovation, Tennessee Oncology; Senior Director of Digital Innovation, OneOncology
    2025/08/11
    AI can succeed in community oncology by delivering a clear return on investment for physician-owners while also restoring the vital human connection between doctors and patients. In this episode, Larry Bilbrey, Director of Data Insights and Innovations at Tennessee Oncology and Senior Director of Digital Innovation at OneOncology, shares the complex journey of driving AI adoption across a national network of cancer-care providers. He highlights the financial realities faced by private practices, where every technology investment is measured by its ability to generate or save money, often boiling down to the question, "Would you spend a dollar to make two or save two?" Larry examines the difficulty of scaling AI solutions across practices with vastly different sizes, resources, and levels of openness to change, from early adopters to more cautious groups. He illustrates the potential impact of AI with a real-world example of an ambient scribe that won over a skeptical physician by restoring his weekends, underscoring the powerful but often intangible return on investment in physician well-being and freeing the long-trapped potential of unstructured clinical data. Tune in and learn why tech founders must build financially accessible, vertically integrated platforms to truly meet the needs of modern oncology practices! Resources: Follow and connect with Larry Bilbrey on LinkedIn. Learn more about OneOncology on LinkedIn and explore their website. Discover more about Tennessee Oncology on LinkedIn and their website.
    続きを読む 一部表示
    50 分
  • Ep. 1 Community Oncology and the Evolving Future of Cancer Care | Dr. Gury Doshi, Medical Director, Texas Oncology; Chair, P&T, U.S. Oncology Network

    Ep. 1 Community Oncology and the Evolving Future of Cancer Care | Dr. Gury Doshi, Medical Director, Texas Oncology; Chair, P&T, U.S. Oncology Network
    2025/08/11
    The future of cancer care lies in the combination of cutting-edge AI and compassionate, community-based treatment. In the first episode, Dr. Gury Doshi, Medical Director at Texas Oncology and Chair, P&T at US Oncology Network, highlights how technology is transforming cancer care and clinician well-being. She explains that community oncology now delivers over 70% of treatments outside academic centers, making it essential to support innovation in these settings. Dr. Doshi discusses how ambient AI is reducing administrative burdens, helping physicians recover 3.5 hours per week, and enhancing both caregiver engagement and the quality of patient interactions. Looking ahead, she envisions AI playing a pivotal role in accelerating clinical trials, improving patient matching, and enabling more personalized, comprehensive care. Tune in and learn how ambient AI is not just relieving paperwork but quietly revolutionizing how we understand, treat, and live with cancer! Resources: Follow and connect with Dr. Gury Doshi on LinkedIn. Learn more about Texas Oncology on LinkedIn and explore their website.
    続きを読む 一部表示
    41 分